Lina M. Ariza-Serrano

Lina M. Ariza-Serrano, M.D


Journal articles

2013	Alfredo E Romero-Rojas, Julio A Diaz-Perez, Lina M Ariza-Serrano, Fabian E Neira-Escobar (2013) Primary Angiosarcoma: Descripcion of a highly aggressive spinal neoplasm. Orthopaedic Surgery Abstract: Notes:
	Alfredo E Romero-Rojas, Julio A Diaz-Perez, Abhinay Reddy, Lina M Ariza-Serrano, Deirdre E Amaro (2013) Aggressive Features in 5 Cases of Primary Gliosarcoma are in Correlation with a Histopathologic and Immunohistochemical Profile that Includes Variable Types of Dedifferentiation Arquivos de Neuro-Psiquiatria Abstract: Notes:
2012	DOI PMID Alfredo E Romero-Rojas, Julio A Díaz-Pérez, Lina M Ariza-Serrano (2012) CD99 is expressed in chordoid glioma and suggests ependymal origin. Virchows Arch 460: 1. 119-122 Jan Abstract: Notes:
	DOI PMID Julio A Diaz-Perez, Lina M Ariza-Serrano, Juan S Barajas-Gamboa (2012) Like paper: a young woman delivered twins, but one was lost well before delivery. Am J Obstet Gynecol 206: 6. Jun Abstract: Notes:
Conference papers

2011	J A Diaz-Perez, J S Barajas-Gamboa, L M Ariza-Serrano, N Weidner, T J Kipps, J E Castro (2011) Chronic Lymphocytic Leukemia Associated with Glomerular Disease: A Case Report of Successful Treatment with High-Dose Methyl-Prednisolone in combination with Rituximab Followed by Alemtuzumab. Clinical Lymphoma Myeloma and Leukemia, October 2011, Vol. 11 Supplement 2, Page S282- S283. Abstract: Notes:
	J S Barajas-Gamboa, J A Diaz-Perez, L M Ariza-Serrano, J M Horton, D F James, A Ale-Ali, T J Kipps, J E Castro (2011) Ofatumumab in Combination with High-Dose Methylprednisolone as a Salvage Treatment for Heavily Pretreated or Refractory Patients with Chronic Lymphocytic Leukemia. Clinical Lymphoma Myeloma and Leukemia , October 2011, Vol. 11 Supplement 2, Page S283. Abstract: Notes:
	J E Castro, J S Barajas-Gamboa, J A Diaz-Perez, L M Ariza-Serrano, J Melo-Cardenas, M Rodriguez, M Urquiza, T J Kipps (2011) Heat Shock Protein 90 (Hsp90) Activity Status Is An Independent Prognostic Marker in Chronic Lymphocytic Leukemia (CLL) and Correlates with IgVH Mutational Status, ZAP-70 Expression and Time to First Treatment. Blood 2011: Abstract 2544. Abstract: Notes:
	J E Castro, J S Barajas-Gamboa, J A Diaz-Perez, L M Ariza-Serrano, S Corringham, T J Kipps, E D Ball (2011) Improved Outcome in Unrelated Donor Recipients After Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Advanced Relapse / Refractory Chronic Lymphocytic Leukemia. Blood 2011: Abstract 4474. Abstract: Notes:
	J E Castro, L M Ariza-Serrano, JS Barajas Gamboa, J A Diaz-Perez, D F James, A Ale-Ali, T J Kipps (2011) Eradication of Minimal Residual Disease Using Alemtuzumab Consolidation After High-Dose Methyl-Prednisolone Plus Rituximab (HDMP-R) Is Safe, Effective and Induces Long Term Remission in Chronic Lymphocytic Leukemia. Edited by:Blood 2011: Abstract 2866.. Abstract: Notes:

Journal articles

Conference papers